Andover, Mass., USA - Royal Philips Electronics (NYSE: PHG, AEX: PHI) has introduced three new respiratory support devices: the Respironics V60 and V200, and Trilogy100 ventilators. These ventilation solutions are intended to support breathing in the intensive care, sub-acute, and home care settings. As a family of products, the three devices are well-suited to address the ventilation care challenges that clinicians face on a daily basis, such as treating respiratory failure from exacerbations of chronic obstructive pulmonary disease (COPD) while avoiding ventilator-associated pneumonia.

Respironics V60 Ventilator
Following its acquisition of Respironics, Philips extends its recognized leadership in noninvasive ventilation (NIV) with the Respironics V60 Ventilator. It provides traditional invasive respiratory support with a tube inserted into the patient's windpipe or noninvasive support via a patient face mask. "Noninvasive ventilation has been proven to significantly reduce the incidence of ventilator-associated pneumonia (VAP), and it has also been shown to shorten the time patients spend in the hospital," says Randy Whitfield, general manager of Hospital Respiratory Care, for Philips Healthcare.

Respironics V200 Critical Care Ventilator
The Respironics V200 Critical Care Ventilator, scheduled for release in June 2009, integrates auto-adaptive technology and provides ventilation for neonatal, pediatric and adult patients. The innovative speaking mode, found on only the Respironics V200 and Esprit ventilators, provides the tracheostomized patient the ability to speak without the need for costly external valves. Ryan Zumalt, director of Respiratory Care at Northern California Rehab Hospital, says, "The speaking mode really boosts the confidence of the patient, making them more apt to progress through the day and work with physical therapy, nursing, and respiratory therapy."

Trilogy100 Ventilator
Trilogy100 is a highly-versatile, lightweight (11 lbs.) life-support ventilator that meets the needs of a wide range of patients in the home and alternative care settings. Trilogy100 has many advanced features, such as auto-adaptive technology, volume- or pressure- control ventilation and the ability to ventilate with either a mask or a tracheal tube.

"Trilogy100 has been designed to help caregivers and clinicians more easily administer care in the home and allow patients to be as active as possible while using the ventilator," says John Frank, vice president and general manager, Home Respiratory Care, for Philips Healthcare. "Its ease of use, versatility, and portability make Trilogy100 a significant advancement in home respiratory support."

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of $38 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at http://www.philips.com/media.